Delisting of Securities of iFresh Inc. and Odonate Therapeutics, Inc. from The Nasdaq Stock Market

(Low)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

The Nasdaq Stock Market has announced the delisting of iFresh Inc. and Odonate Therapeutics, Inc. iFresh’s common stock was suspended on November 23, 2021, while Odonate's was suspended on January 18, 2022. Both companies have not traded on Nasdaq since their respective suspension dates. Nasdaq will file a Form 25 with the SEC to finalize the delistings, which will take effect ten days after the filing. Investors seeking further information about these companies should consult their public filings or contact them directly.

Positive

None.

Negative

iFresh Inc. and Odonate Therapeutics have been suspended from trading on Nasdaq.
Both companies will be delisted, impacting their market accessibility.
The delisting process indicates significant financial or operational problems within these companies.

Argus Session date unavailable

-0.77% session move Open Argus

Details

News Market Reaction – NDAQ

The recorded move for NDAQ in the trading session of this news was -0.77%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

01/24/2022 - 04:05 PM

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of iFresh Inc. iFresh Inc.’s common stock was suspended on November 23, 2021 and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.’s common stock was suspended on January 18, 2022 and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

NDAQO

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why is iFresh Inc. being delisted from Nasdaq?

iFresh Inc. is being delisted due to being suspended from trading since November 23, 2021.

What led to the suspension of Odonate Therapeutics, Inc.?

Odonate Therapeutics, Inc. was suspended from trading on Nasdaq on January 18, 2022.

What is the process for delisting iFresh Inc. and Odonate Therapeutics?

Nasdaq will file a Form 25 with the SEC to complete the delistings, effective ten days after filing.

What happens to the stocks of iFresh Inc. and Odonate Therapeutics after delisting?

After delisting, the stocks may not be traded on Nasdaq and investors should check for other trading venues.

What should investors do after the announcement of delistings for NDAQ stocks?

Investors should review public filings of the companies and consider contacting them for more detailed information.

Delisting of Securities of iFresh Inc. and Odonate Therapeutics, Inc. from The Nasdaq Stock Market